Exploring patient satisfaction with long-term warfarin for the treatment of atrial fibrillation.

被引：2
|
作者：
Murray, M
Wild, D
Reaney, M
机构：
[1] Bayer Plc, Global Hlth Econ & Reimbursement, Uxbridge, Middx, England
[2] Oxford Outcomes, Oxford, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2245.2245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2245
引用
收藏
页码：632A / 633A
页数：2
相关论文
共 50 条
  • [31] Treatment of atrial fibrillation. A perspective question?
    de Diego Rus, Carlos
    Almendral Garrote, Jesus
    MEDICINA CLINICA, 2011, 137 (06): : 257 - 258
  • [32] Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study
    Ng, Diana-Leh-Ching
    Malik, Natasya Marliana Bt Abdul
    Chai, Chee-Shee
    Goh, Greta-Miranda-Kim-Choo
    Tan, Seng-Beng
    Bee, Ping-Chong
    Gan, Gin-Gin
    Said, Asri B.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
  • [33] Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study
    Diana-Leh-Ching Ng
    Natasya Marliana Bt Abdul Malik
    Chee-Shee Chai
    Greta-Miranda-Kim-Choo Goh
    Seng-Beng Tan
    Ping-Chong Bee
    Gin-Gin Gan
    Asri B. Said
    Health and Quality of Life Outcomes, 18
  • [34] Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.
    Ozcan, C
    Jahangir, A
    Friedman, PA
    Patel, PJ
    Munger, TM
    Rea, RF
    Lloyd, MA
    Packer, DL
    Hodge, DO
    Gersh, BJ
    Hammill, SC
    Shen, WK
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1043 - 1051
  • [35] Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation
    Song, Xue
    Sander, Stephen D.
    Varker, Helen
    Amin, Alpesh
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 245 - 253
  • [36] Long-Term Persistence of Newly Initiated Warfarin Therapy in Chinese Patients With Nonvalvular Atrial Fibrillation
    Wang, Zhi-Zun
    Du, Xin
    Wang, Wei
    Tang, Ri-Bo
    Luo, Jing-Guang
    Li, Chao
    Chang, San-Shuai
    Liu, Xiao-Hui
    Sang, Cai-Hua
    Yu, Rong-Hui
    Long, De-Yong
    Wu, Jia-Hui
    Bai, Rong
    Liu, Nian
    Ruan, Yan-Fei
    Dong, Jian-Zeng
    Ma, Chang-Sheng
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2016, 9 (04): : 380 - 387
  • [37] IS LONG-TERM WARFARIN THERAPY NECESSARY IN PATIENTS WITH MITRAL BIOPROSTHETIC VALVES PLUS ATRIAL FIBRILLATION?
    Zhang, L.
    Jiang, S.
    Ren, C.
    Xiao, C.
    Wang, R.
    Gao, C.
    HEART, 2015, 101 : A29 - A29
  • [38] Tracheobronchial calcification: an incidental finding in a patient on long-term Warfarin treatment
    Kedar, Aishwarya Kishor
    Alone, Vivek Dipakrao
    PAN AFRICAN MEDICAL JOURNAL, 2024, 48
  • [39] Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation
    Xue Song
    Stephen D. Sander
    Helen Varker
    Alpesh Amin
    American Journal of Cardiovascular Drugs, 2012, 12 (4) : 245 - 253
  • [40] The cost-effectiveness of warfarin (Coumadin®) vs. ximelagatran (Exanta®) for the treatment of atrial fibrillation.
    Ellis, SL
    Ulrich, HC
    Arant, TW
    Sullivan, PW
    PHARMACOTHERAPY, 2005, 25 (03): : 471 - 471
12345